GSK and RB quiet on Pfizer but talk acquisitions

26 February 2018 - Deborah Wilkes

Archived

GlaxoSmithKline and RB are keeping quiet on reports that they are the only two bidders for Pfizer's Consumer Healthcare business. However, the two chief executive officers have plenty to say about their prudent approach to big consumer healthcare acquisitions.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: